NCT00701740View on ClinicalTrials.gov

Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

June 30, 2008

Conditions
PhotoagingEpidermal p53 Expression
Interventions
DRUG

oral isotretinoin and Mexoryl SX / XL

20mg, 3/week,continuously for three months

DRUG

Mexoryl XL / SX

11 subjects used only the same moisturizer and SPF 60 sunscreen

Trial Locations (1)

04023-900

Federal University of Sao Paulo, São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT00701740 - Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial | Biotech Hunter | Biotech Hunter